Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring

Journal of Pathology

Volumn 235, Issue 4, 2015, Pages 619-631

  Hawkes, Cheryl A ^a   Gentleman, Steve M ^b   Nicoll, James A ^a   Carare, Roxana O ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid; Brain; Cerebral vasculature; Maternal obesity

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; COLLAGEN TYPE 4; FIBRONECTIN; CHOLESTEROL; SCLEROPROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BASEMENT MEMBRANE; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LACTATION; LIPID DIET; MACROPHAGE; MATERNAL OBESITY; MOUSE; NONHUMAN; PERICYTE; PHENOTYPE; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; STRUCTURE ANALYSIS; UPREGULATION; VASCULAR AMYLOIDOSIS; ADVERSE EFFECTS; AGE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL; ANIMAL FOOD; BRAIN; BRAIN ARTERY; C57BL MOUSE; CASE CONTROL STUDY; CEREBRAL AMYLOID ANGIOPATHY; COMPLICATION; GESTATIONAL AGE; HUMAN; MATERNAL NUTRITION; METABOLISM; NUTRITIONAL STATUS; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; TIME;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; BASEMENT MEMBRANE; BRAIN; CASE-CONTROL STUDIES; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL ARTERIES; CHOLESTEROL; DIET, HIGH-FAT; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GESTATIONAL AGE; HUMANS; HYPERCHOLESTEROLEMIA; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICE, INBRED C57BL; NUTRITIONAL STATUS; OBESITY; PLAQUE, AMYLOID; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TIME FACTORS;

EID: 84922754904     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4468     Document Type: Article

References (55)

1. Kivipelto M, Solomon A. Alzheimer's disease-the ways of prevention. J Nutrit Health Aging 2008; 12: 89-94S.
2. Paulus W. Lifestyle neuropathology: how our behavior harms our brains and what we can do about it. Acta Neuropathol 2014; 127: 1.
3. Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med 2010; 15: 70-76.
4. Parlee SD, Macdougald OA. Maternal nutrition and risk of obesity in offspring: the Trojan horse of developmental plasticity. Biochim Biophys Acta 2014; 1842: 495-506.
5. Reynolds RM, Allan KM, Raja EA, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular eventin adult offspring: follow-up of 1 323 275 person-years. Br Med J 2013; 347: f4539.
6. Lahiri DK, Zawia NH, Greig NH, et al. Early-life events may trigger biochemical pathways for Alzheimer's disease: the 'LEARn' model. Biogerontology 2008; 9: 375-379.
7. Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiat 2009; 14: 992-1003.
8. Paris D, Patel N, DelleDonne A, et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 2004; 366: 80-85.
9. Shin HK, Jones PB, Garcia-Alloza M, et al. Age-dependent cere-brovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007; 130: 2310-2319.
10. Beckmann N, Schuler A, Mueggler T, et al. Age-dependent cerebrovascular abnormalities and blood fow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 2003; 23: 8453-8459.
11. Pfeifer LA, White LR, Ross GW, et al. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002; 58: 1629-1634.
12. Schrag M, Crofton A, Zabel M, et al. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease. J Alzheimer's Dis 2011; 24: 137-149.
13. Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of P-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009; 117: 309-320.
14. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes 243. Stroke 1983; 14: 924-928.
15. Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS P-amyloid in Alzheimer's disease. Science 2010; 330: 1774.
16. Neuwelt EA, Bauer B, Fahlke C, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 2011; 12: 169-182.
17. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011; 12: 723-738.
18. Hawkes CA, Gatherer M, Sharp MM, et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-p from the mouse brain. Aging Cell 2013; 12: 224-236.
19. Hawkes CA, Hartig W, Kacza J, et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol 2011; 121:431-443.
20. Hawkes CA, Sullivan PM, Hands S, et al. Disruption of arterial perivascular drainage of amyloid-p from the brains of mice expressing the human APOE e4 allele. PloS One 2012; 7: e41636.
21. Refolo LM, Malester B, LaFrancois J, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7: 321-331.
22. Shie FS, Jin LW, Cook DG, et al. Diet-induced hypercholesterolemia enhances brain Ap accumulation in transgenic mice. NeuroReport 2002; 13: 455-459.
23. Bruce KD, Cagampang FR, Argenton M, et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009; 50: 1796-1808.
24. Elliott DA, Weickert CS, Garner B. Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin Lipidol 2010; 51: 555-573.
25. Lefterov I, Fitz NF, Cronican AA, et al. Apolipoprotein A-I def-ciency increases cerebral amyloid angiopathy and cognitive defcits in APP/PS1AE9 mice. J Biol Chem 2010; 285: 36945-36957.
26. Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem 2005; 280: 43224-43235.
27. Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of P-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009; 106: 1261-1266.
28. Thal DR, Larionov S, Abramowski D, et al. Occurrence and co-localization of amyloid P-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 2007; 28: 1221-1230.
29. Deane R, Sagare A, Hamm K, et al. apoE isoform-specifc disruption of amyloid P-peptide clearance from mouse brain. J Clin Invest 2008; 118: 4002-4013.
30. Solomon A, Kivipelto M, Wolozin B, et al. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dementia Geriatr Cogn Disord 2009; 28: 75-80.
31. Christov A, Ottman J, Hamdheydari L, et al. Structural changes in Alzheimer's disease brain microvessels. Curr Alzheimer Res 2008; 5: 392-395.
32. Berzin TM, Zipser BD, Rafi MS, et al. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 2000; 21:349-355.
33. Mancardi GL, Perdelli F, Rivano C, et al. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol 1980; 49: 79-83.
34. Perlmutter LS. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol 1994; 9: 33-40.
35. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-245.
36. Barker DJ, Martyn CN. The maternal and fetal origins of cardiovascular disease. J Epidemiol Community Health 1992; 46: 8-11.
37. Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010; 140: 387-398.
38. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and infammatory pathways. J Clin Endocrinol Metab 2002; 87: 4231-4237.
39. Lahiri DK, Maloney B. The 'LEARn' (Latent Early life-Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps. Exp Gerontol 2010; 45: 291-296.
40. Lahiri DK, Maloney B, Basha MR, et al. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the 'LEARn' model (latent early life-associated regulation) may explain the triggering of AD. Curr Alzheimer Res 2007; 4: 219-228.
41. Lahiri DK. Prions: a piece of the puzzle? Science 2012; 337: 1172.
42. Wu C, Ivars F, Anderson P, et al. Endothelial basement membrane laminin-α5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 2009; 15: 519-527.
43. Arbel-Ornath M, Hudry E, Eikermann-Haerter K, et al. Interstitial fuid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol 2013; 126: 353-364.
44. Carare RO, Bernardes-Silva M, Newman TA, et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: signifcance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 2008; 34: 131-144.
45. Skeik N, Porten BR, Delgado Almandoz JE, et al. A unique case report of cerebral amyloid angiopathy with literature review. Ann Vasc Surg 2014; 28: 1316, e1311-1316.
46. Bandopadhyay R, Orte C, Lawrenson JG, et al. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers. J Neuro-cytol 2001; 30: 35-44.
47. Gearing M, Schneider JA, Robbins RS, et al. Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 1995; 54: 833-841.
48. Verghese PB, Castellano JM, Garai K, et al. ApoE infuences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci USA 2013; 110: E1807-1816.
49. Bell RD, Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipopro-teins E and J in the mouse central nervous system. J Cerebr Blood Flow Metab 2007; 27: 909-918.
50. Aleshkov S, Abraham CR, Zannis VI. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide-β (1-40). Relevance to Alzheimer's disease. Biochemistry 1997; 36: 10571-10580.
51. Tokuda T, Calero M, Matsubara E, et al. Lipidation of apolipopro-tein E infuences its isoform-specifc interaction with Alzheimer's amyloid-β peptides. Biochem J 2000; 348: 359-365.
52. Shimizu H, Ghazizadeh M, Sato S, et al. Interaction between β-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease. J Clin Neurosci 2009; 16: 277-282.
53. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002; 13: 48-52.
54. Raikkonen K, Kajantie E, Pesonen AK, et al. Early life origins cognitive decline: fndings inelderly men in the Helsinki Birth Cohort Study. PloS One 2013; 8: e54707.
55. Bergen WG, Mersmann HJ. Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J Nutr 2005; 135: 2499-2502.